These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27023737)

  • 1. Delta-opioid receptors as targets for migraine therapy.
    Charles A; Pradhan AA
    Curr Opin Neurol; 2016 Jun; 29(3):314-9. PubMed ID: 27023737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.
    Pradhan AA; Smith ML; Zyuzin J; Charles A
    Br J Pharmacol; 2014 May; 171(9):2375-84. PubMed ID: 24467301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
    Dripps IJ; Bertels Z; Moye LS; Tipton AF; Siegersma K; Baca SM; Kieffer BL; Pradhan AA
    Sci Rep; 2020 Oct; 10(1):17629. PubMed ID: 33077757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodynia.
    Bertels Z; Witkowski WD; Asif S; Siegersma K; van Rijn RM; Pradhan AA
    Headache; 2021 Jan; 61(1):170-178. PubMed ID: 33326598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.
    Ananthan S
    AAPS J; 2006 Mar; 8(1):E118-25. PubMed ID: 16584118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.
    Berthiaume S; Abdallah K; Blais V; Gendron L
    J Neural Transm (Vienna); 2020 Apr; 127(4):661-672. PubMed ID: 32189076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).
    Fujii H; Takahashi T; Nagase H
    Expert Opin Ther Pat; 2013 Sep; 23(9):1181-208. PubMed ID: 23705966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta and kappa opioid receptors as suitable drug targets for pain.
    Vanderah TW
    Clin J Pain; 2010 Jan; 26 Suppl 10():S10-5. PubMed ID: 20026960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
    Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
    Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mu, delta and kappa properties of various opioids].
    Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.
    Fraser GL; Gaudreau GA; Clarke PB; Ménard DP; Perkins MN
    Br J Pharmacol; 2000 Apr; 129(8):1668-72. PubMed ID: 10780972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
    Kakinohana M; Nakamura S; Fuchigami T; Davison KJ; Marsala M; Sugahara K
    Br J Anaesth; 2006 Jan; 96(1):88-94. PubMed ID: 16317029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.